CRISIL assigns ratings to Lincoln Pharmaceuticals’ bank facilities

19 Mar 2019 Evaluate

Credit rating agency, CRISIL has assigned rating to Lincoln Pharmaceuticals’ bank facilities worth Rs 93.41 crore. The agency has assigned ‘A- /Stable’ rating to the company’s long term bank loan facilities and ‘A2+’ rating to short term bank loan facilities.

Lincoln Pharmaceuticals is engaged in the manufacture and marketing of affordable therapeutic products. The product range of the company includes Tablets, Capsules, Injectable, Syrups and Ointments. 

Lincoln Pharma Share Price

481.40 -7.35 (-1.50%)
10-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.25
Dr. Reddys Lab 1251.10
Cipla 1489.15
Zydus Lifesciences 923.70
Lupin 2055.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×